Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility.

Ali AfrasiabiGrant P ParnellNicole FewingsStephen D SchibeciMonica A BasukiRamya ChandramohanYuan ZhouBruce TaylorDavid A BrownSanjay SwaminathanFiona C McKayGraeme J StewartDavid R Booth

Published in: Genome medicine (2019)

These data indicate targeting EBV may be of therapeutic benefit in MS.

Keyphrases

epstein barr virus
multiple sclerosis
genome wide association
diffuse large b cell lymphoma
electronic health record
white matter
cancer therapy
big data
case control
mass spectrometry
machine learning
drug delivery